Kurzfassung

A randomized, non-comparative, open-label, multicenter, phase II trial evaluating the safety and activity of DCDT2980S in combination with Rituximab or DCDS4501A in combination with Rituximab in patients with relapsed or refractory B-cell Non-Hodgkin`s Lymphoma